Presenter: Electron Kebebew, MD
Harry Oberhelman Jr. and Mark Welton Professor of Surgery
Electron Kebebew, MD, is an internationally recognized expert in Endocrine Oncology and Surgery. He has performed more than three thousand operations on the adrenal, parathyroid and thyroid glands, and for neuroendocrine tumors of the gastrointestinal tract and pancreas.
Kebebew has published over 400 articles, chapters and textbooks, and serves on the editorial board and as a reviewer for 54 biomedical journals. He has received awards from the American Cancer Society, American Association for Cancer Research, American Thyroid Association, American Association of Endocrine Surgeons, and International Association of Endocrine Surgeons.
Come enjoy hors-d’oeuvres, wine, and meet with your School of Medicine women faculty colleagues.
We are delighted to be joined by Special guests Lloyd Minor, MD and Linda Boxer, MD, PhD.
Please RSVP
RSVP to Kathleen Victor kvictor@stanford.edu.
Lloyd Minor, MD
Dean of the School of Medicine
Professor of Otolaryngology—Head & Neck Surgery and, by courtesy, of Neurobiology and Bioengineering
Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine, a position he has held since December 1, 2012. He is also a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University.
Dr. Linda Boxer
Vice Dean, School of Medicine
Professor of Medicine-Hematology
Linda M. Boxer, MD, PhD, is the Vice Dean, Stanley McCormick Memorial Professor in the School of Medicine, and Chief of the Division of Hematology. Dr. Boxer’s clinical expertise is in hematology malignancies. She serves as an attending physician on the inpatient hematology consult service. Dr. Boxer has mentored many trainees, especially physician scientists, and she has helped with their development into independent investigators.
The Canary Center at Stanford, founded in 2009 as the first research center in the world, entirely dedicated to cancer early detection, The Knight Cancer Institute at Oregon Health & Science University, a leader in precision cancer medicine, and Cancer Research UK, the largest independent funder of cancer research globally have formed an international collaboration to accelerate research in the early detection of cancer.
The goal of this unique trans-Atlantic agreement is to find lethal cancers as they’re forming so they can be treated more effectively. Survival increases significantly when the disease is treated at an early stage.
The collaboration also seeks to accelerate progress by breaking down barriers for scientists, including:
- A lack of cohorts of sufficient size and a shortage of clinical samples available for research
- Development and deployment of new technologies
- Lack of understanding of the biology of early cancer and technologies to detect its features
2019 conference topic list includes:
- Integrative Early Detection through multiple technologies
- Prognostic Early Detection
- Signals from beyond the tumor
- Integrative Susceptibility for Early Detection
- Fostering a translational mentality in Early Detection Research
Register here.
Lunch will be provided.
This event is sponsored by the School of Medicine Office of Faculty Development and Diversity.
ACTING WITH POWER
Exploring your personal relationship to power, status and authority allows you to navigate nuanced organizational and communication dynamics with increased agility. This agility helps you accomplish your strategic, operational and professional objectives. Cultivating your Presence & Power requires alignment of self-perceptions and perceptions that others have of you. Expanding your authentic delivery range can change how we are perceived. Combining performance techniques and data from the fields of social psychology and gender research, this highly interactive session provides insight into how behavioral range – physical, vocal, intellectual, mindset, strategic – affects your impact. Objectives for the workshop may include:
- Obtain deeper understandings of power, status and authority
- Learn to observe and understand the behaviors that underlie power and
- status dynamics
- Learn how to use power constructively
- Learn to use your voice and body most effectively
- Learn to identify and use under-utilized parts of yourself
- Develop a broader repertoire of useful verbal & non-verbal behaviors
Kay Kostopoulos directs and teaches acting, acting pedagogy, musical theater, voice, speech, and Shakespeare in the Department of Theater and Performance Studies (TAPS) and Continuing Studies Program at Stanford University. She teaches “Acting with Power” at Stanford’s Graduate School of Business, and has coached for the Knight Fellows Journalism Program, the Clayman Institute for Gender Research, and the Department of English. Kay has created and directed many training programs for Stanford’s School of Medicine.
She has also taught private seminars for Apple, Twitter, Airbnb, Genentech, Cisco, Sony Pictures, Hitachi, Thermo Fisher Scientific, Lippincott, Ernst and Young, First Republic, Stanford’s Executive Program for Women and Women in Entrepreneurship Program, eBay’s Global Women’s Conference and Women In Cable Telecommunications. Her work has been featured in “O” magazine. http://www.oprah.com/spirit/Body-Language-Signs-Body-Language-of-Women/2and she has been featured on NPR’s Philosophy Talk radio program http://philosophytalk.org/shows/faces-feelings-and-liesfor her work on understanding facial emotions in the treatment of Autism.
Melissa Jones Briggs is a Lecturer at Stanford University’s Graduate School of Business. Trained as a theatre artist in London and New York, Jones Briggs specializes in performance as a tool for social change. She is a founding member of the teaching team for the renowned Acting with Power course at the GSB, she lectures in several Stanford Executive Programs, and coaches at the Clayman Institute for Gender Research. Melissa is especially passionate about inclusive leadership. Outside academia, Melissa designs, directs & deploys global leadership programs for corporations, NGOs, academic and federal institutions. As a speaker, she engages audiences around the world on topics like power, performance and inclusion. As a teaching artist, she developed devised performance curricula for underserved and severe special needs youth. She now serves as a Member of the Board of Directors at Youth in Arts, an arts education and social justice non-profit in the San Francisco Bay Area. Melissa studied at Wake Forest University, the Royal Academy of Dramatic Art, the Actors Center New York, and she has guest taught at London Business School, Aalto University in Helsinki, Finland and the United States Naval Academy.
Location
Li Ka Shing Center – LK101
291 Campus Drive
Stanford, CA 94305
Contact Information
Kathleen Victor
Phone: 650-724-0239
kvictor@stanford.edu
Registration Open Until Tuesday, November 5, 2019 3:00 PM (EST)
Please join us with special guest Phil Pizzo, Former Dean, Stanford School of Medicine and Founding Director of the Stanford Distinguished Careers Institute, April 1, 2020, 12:00-1:30pm, location TBD. RSVP to Kathleen Victor.
Tanja Gruber, MD, PhD is the Division Chief of Pediatric Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine and Director of the Bass Center for Cancer and Blood Disorders. She is a product of the University of Washington, with dual BS degrees in Biology and Biochemistry; University of Southern California, there with MD in Medicine and PhD in Immunology; and Children’s Hospital of Los Angeles for Internship and Residency in Pediatrics and then Fellowship in Hematology and Oncology. Dr. Gruber was recruited after fellowship to St. Jude Children’s Research Hospital, where she became a nationally and internationally recognized physician- scientist. At St. Jude she focused on high-risk leukemia and acute megakaryoblastic leukemia (AMKL). Her laboratory research has led to the identification of CBFA2T3-GLIS2, a novel fusion gene that confers a poor prognosis in pediatric AMKL, and a detailed view of the genomic landscape in MLLr leukemia.
Join us on Zoom: https://bit.ly/2ZLtI1S Password: 576948